Why Does Mounjaro Feel Like It's Wearing Off?

Is it normal for Mounjaro to feel stronger early in the week?

Yes, and it follows directly from the medicine's half-life. After a weekly injection, tirzepatide reaches its highest concentration in the bloodstream roughly one to three days later, then begins a steady decline over the remaining days. That trajectory means most people feel the most pronounced reduction in appetite and the strongest sense of fullness mid-week, with appetite beginning to reassert itself toward day five, six or seven. If you've noticed your hunger returning more sharply on those later days, the pattern across a typical injection week explains why.

This isn't a flaw in the medicine, and it doesn't mean the treatment isn't working. It's simply the pharmacokinetics playing out as expected. The clinical trials that established Mounjaro's effectiveness (including SURMOUNT-1, in which participants lost an average of around 20% of body weight over 72 weeks) were designed around once-weekly dosing, late-week dip and all. The dose schedule accounts for it. The NHS patient information page for tirzepatide gives a clear overview of how the medicine works.

One misconception worth addressing gently: some people assume that if they can feel hungry again by day six, the injection 'didn't take'. That's not how it works. A narrowing of appetite suppression near the end of the cycle is consistent with effective treatment. A complete and early return of hunger, by contrast, is something different, and worth discussing.

What does it mean if the effect seems to be fading over several weeks?

A different pattern can emerge over months rather than days. Some people find that a dose which felt powerful at first becomes less noticeable after eight or twelve weeks. Weight loss may slow or plateau, and appetite may return to something closer to pre-treatment levels. This is sometimes described as 'tolerance', though the mechanisms aren't fully characterised for tirzepatide specifically.

In practice, this is one of the clearest signals that a dose increase may be appropriate. Mounjaro's licensed schedule runs from 2.5 mg up through 5, 7.5, 10, 12.5 and 15 mg, with each step typically introduced at four-week intervals. The earlier doses are the body's settling-in period; the therapeutic work often deepens as the dose increases. For many people, a sense of 'wearing off' at a lower dose resolves once they move up the schedule under prescriber guidance. You can read more about when this effect typically sets in and what it signals.

At nume, at nume, a prescriber personally reviews every repeat order before it's dispensed. That review is the moment to flag a fading effect, because increasing the dose without clinical re-assessment isn't something that should happen automatically. Effective treatment isn't set-and-forget.

Could something else explain why Mounjaro seems less effective?

Occasionally the answer lies outside the medicine itself. Sleep quality, chronic stress, dietary composition and activity levels all influence appetite signalling, and a period of disrupted sleep or elevated cortisol can make hunger feel louder regardless of what's in your bloodstream. That doesn't mean the medicine has stopped working; it means other signals are competing with it.

Injection technique and storage conditions matter too. Tirzepatide must be kept refrigerated at 2–8°C; a pen that has been left at room temperature for longer than the window described in the Patient Information Leaflet may have reduced potency. The eMC hosts the full Mounjaro SmPC, including exact storage guidance. Rotating injection sites (abdomen, thigh and upper arm) can also help maintain consistent absorption.

If you've ruled out lifestyle and storage factors and the effect is still noticeably weaker, the question of whether your current dose remains clinically appropriate is one for your prescriber. Some people find the end-of-week dip sharpens at lower doses and resolves after titration. That's a clinical assessment, not a guess.

When should you actually speak to a prescriber about this?

A single day of feeling hungrier than usual near injection day is rarely cause for concern. A persistent, week-on-week sense that appetite suppression is gone, that weight has plateaued or started to reverse, or that you're struggling to sustain the reduced food intake that was manageable before, those are worth flagging.

Similarly, if you're experiencing anything that feels like a side effect rather than reduced efficacy (stomach discomfort, nausea that isn't settling, or any symptom you're unsure about) your prescriber should hear about it. Side-effect questions can sometimes be confused with 'wearing off' and vice versa. If day five is consistently the hardest day of your week, that's a specific and useful piece of information to bring to a clinical review.

On the question of cost: people sometimes push through an obvious fading effect rather than raise it, partly out of concern about what adjusting treatment might involve. For context on what private Mounjaro treatment typically costs across doses, our cost overview sets out the landscape plainly. If you'd like a prescriber to review how your treatment is going, checking your eligibility is the starting point.